These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 12096119)

  • 1. A distinct repertoire of autoantibodies in hepatocellular carcinoma identified by proteomic analysis.
    Le Naour F; Brichory F; Misek DE; Bréchot C; Hanash SM; Beretta L
    Mol Cell Proteomics; 2002 Mar; 1(3):197-203. PubMed ID: 12096119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibodies to survivin in patients with chronic hepatitis and hepatocellular carcinoma.
    Yagihashi A; Asanuma K; Kobayashi D; Tsuji N; Torigoe T; Sato N; Watanabe N
    Autoimmunity; 2005 Sep; 38(6):445-8. PubMed ID: 16278150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calreticulin is a B cell molecular target in some gastrointestinal malignancies.
    Pekáriková A; Sánchez D; Palová-Jelínková L; Simsová M; Benes Z; Hoffmanová I; Drastich P; Janatková I; Mothes T; Tlaskalová-Hogenová H; Tucková L
    Clin Exp Immunol; 2010 May; 160(2):215-22. PubMed ID: 20030668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: role in the course of chronic viral hepatitis and the development of HCC.
    Fabris C; Falleti E; Cussigh A; Bitetto D; Fontanini E; Bignulin S; Cmet S; Fornasiere E; Fumolo E; Fangazio S; Cerutti A; Minisini R; Pirisi M; Toniutto P
    J Hepatol; 2011 Apr; 54(4):716-22. PubMed ID: 21146242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of hepatocellular-carcinoma-associated antigens and autoantibodies by serological proteome analysis combined with protein microarray.
    Li L; Chen SH; Yu CH; Li YM; Wang SQ
    J Proteome Res; 2008 Feb; 7(2):611-20. PubMed ID: 18161940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
    Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
    Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibody responses in Chinese hepatocellular carcinoma.
    Zhang JY; Wang X; Peng XX; Chan EK
    J Clin Immunol; 2002 Mar; 22(2):98-105. PubMed ID: 11998899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Progressive increase of serum circulating immune complexes and its significance in patients during the progression from chronic hepatitis B to hepatocellular carcinoma].
    Du J; Tian P; Chen TY; Wu JX; Wang JB; Wei Y; Wang LM; Liu LG; Ji WS; Qu CF
    Zhonghua Zhong Liu Za Zhi; 2011 Dec; 33(12):905-10. PubMed ID: 22340099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HBV + HCV = HCC?
    Cramp ME
    Gut; 1999 Aug; 45(2):168-9. PubMed ID: 10403725
    [No Abstract]   [Full Text] [Related]  

  • 10. IL-23 production of liver inflammatory macrophages to damaged hepatocytes promotes hepatocellular carcinoma development after chronic hepatitis B virus infection.
    Zang M; Li Y; He H; Ding H; Chen K; Du J; Chen T; Wu Z; Liu H; Wang D; Cai J; Qu C
    Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3759-3770. PubMed ID: 30292634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Independent and additive interaction between tumor necrosis factor β +252 polymorphisms and chronic hepatitis B and C virus infection on risk and prognosis of hepatocellular carcinoma: a case-control study.
    Jeng JE; Wu HF; Tsai MF; Tsai HR; Chuang LY; Lin ZY; Hsieh MY; Chen SC; Chuang WL; Wang LY; Yu ML; Dai CY; Tsai JF
    Asian Pac J Cancer Prev; 2014; 15(23):10209-15. PubMed ID: 25556449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity of Ra1A and its tissue-specific expression in hepatocellular carcinoma.
    Wang K; Chen Y; Liu S; Qiu S; Gao S; Huang X; Zhang J; Peng X; Qiani W; Zhang JY
    Int J Immunopathol Pharmacol; 2009; 22(3):735-43. PubMed ID: 19822090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
    Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
    Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum DHCR24 Auto-antibody as a new Biomarker for Progression of Hepatitis C.
    Ezzikouri S; Kimura K; Sunagozaka H; Kaneko S; Inoue K; Nishimura T; Hishima T; Kohara M; Tsukiyama-Kohara K
    EBioMedicine; 2015 Jun; 2(6):604-12. PubMed ID: 26288822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathologic characteristics andoutcomes of hepatocellular carcinoma associated with chronic hepatitis B versus hepatitis C infection.
    Aljumah AA; Kuriry H; Faisal N; Alghamdi H
    Ann Saudi Med; 2018; 38(5):358-365. PubMed ID: 30284991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations of pesticides, HCV, HBV, and hepatocellular carcinoma in Egypt.
    Ezzat S; Abdel-Hamid M; Eissa SA; Mokhtar N; Labib NA; El-Ghorory L; Mikhail NN; Abdel-Hamid A; Hifnawy T; Strickland GT; Loffredo CA
    Int J Hyg Environ Health; 2005; 208(5):329-39. PubMed ID: 16217918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing titers and changing specificities of antinuclear antibodies in patients with chronic liver disease who develop hepatocellular carcinoma.
    Imai H; Nakano Y; Kiyosawa K; Tan EM
    Cancer; 1993 Jan; 71(1):26-35. PubMed ID: 8380118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for hepatocellular carcinoma in a cohort infected with hepatitis B or C.
    Walter SR; Thein HH; Gidding HF; Amin J; Law MG; George J; Dore GJ
    J Gastroenterol Hepatol; 2011 Dec; 26(12):1757-64. PubMed ID: 21615789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preneoplastic markers of hepatitis B virus-associated hepatocellular carcinoma.
    Hann HW; Lee J; Bussard A; Liu C; Jin YR; Guha K; Clayton MM; Ardlie K; Pellini MJ; Feitelson MA
    Cancer Res; 2004 Oct; 64(20):7329-35. PubMed ID: 15492253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TLR3 and TLR4 SNP variants in the liver disease resulting from hepatitis B virus and hepatitis C virus infection.
    Sghaier I; Zidi S; Mouelhi L; Ghazoueni E; Brochot E; Almawi WY; Loueslati BY
    Br J Biomed Sci; 2019 Jan; 76(1):35-41. PubMed ID: 30421643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.